The Product Surveillance Registry REVERSE Post Approval Study
NCT ID: NCT01660035
Last Updated: 2022-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
155 participants
OBSERVATIONAL
2012-04-30
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
NCT00271154
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
NCT01466621
PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy
NCT00253357
Renal Denervation in Heart Failure With Preserved Ejection Fraction
NCT01840059
Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum
NCT01035489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has or is intended to receive or be treated with a Medtronic CRT-D who meets the expanded CRT-D indication criteria with a QRS ≤ 150ms
* Patient within 30 days of implant
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, Alabama, United States
Anchorage, Alaska, United States
Chandler, Arizona, United States
Gilbert, Arizona, United States
Jonesboro, Arkansas, United States
Little Rock, Arkansas, United States
Bakersfield, California, United States
Chula Vista, California, United States
Los Angeles, California, United States
Rancho Mirage, California, United States
Redwood City, California, United States
Salinas, California, United States
San Diego, California, United States
Stanford, California, United States
Torrance, California, United States
Van Nuys, California, United States
Colorado Springs, Colorado, United States
Lakewood, Colorado, United States
New Haven, Connecticut, United States
Washington D.C., District of Columbia, United States
Bradenton, Florida, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
Safety Harbor, Florida, United States
Albany, Georgia, United States
Atlanta, Georgia, United States
Marietta, Georgia, United States
Evansville, Indiana, United States
West Des Moines, Iowa, United States
Kansas City, Kansas, United States
Edgewood, Kentucky, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Baton Rouge, Louisiana, United States
Hyattsville, Maryland, United States
Salisbury, Maryland, United States
Silver Spring, Maryland, United States
Takoma Park, Maryland, United States
Lansing, Michigan, United States
Marquette, Michigan, United States
Ypsilanti, Michigan, United States
Coon Rapids, Minnesota, United States
Minneapolis, Minnesota, United States
Robbinsdale, Minnesota, United States
Rochester, Minnesota, United States
Saint Cloud, Minnesota, United States
Saint Paul, Minnesota, United States
Hattiesburg Clinic
Hattiesburg, Mississippi, United States
Columbia, Missouri, United States
Kansas City, Missouri, United States
Lebanon, New Hampshire, United States
Morristown, New Jersey, United States
Ocean City, New Jersey, United States
Ridgewood, New Jersey, United States
Albuquerque, New Mexico, United States
Bay Shore, New York, United States
Huntington, New York, United States
Manhasset, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
Poughkeepsie, New York, United States
Staten Island, New York, United States
The Bronx, New York, United States
Utica, New York, United States
Charlotte, North Carolina, United States
Durham, North Carolina, United States
Raleigh, North Carolina, United States
Akron, Ohio, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Toledo, Ohio, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
Allentown, Pennsylvania, United States
Bethlehem, Pennsylvania, United States
Danville, Pennsylvania, United States
Erie, Pennsylvania, United States
Lancaster, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Wilkes-Barre, Pennsylvania, United States
Wynnewood, Pennsylvania, United States
Columbia, South Carolina, United States
Germantown, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Plano, Texas, United States
San Antonio, Texas, United States
The Woodlands, Texas, United States
Burlington, Vermont, United States
Charlottesville, Virginia, United States
Falls Church, Virginia, United States
Leesburg, Virginia, United States
Olympia, Washington, United States
Spokane, Washington, United States
Tacoma, Washington, United States
Madison, Wisconsin, United States
Milwaukee, Wisconsin, United States
Leuven, , Belgium
Calgary, Alberta, Canada
London, Ontario, Canada
Ottawa, Ontario, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
La Rochelle, , France
Nantes, , France
Essen, , Germany
Hanover, , Germany
Homburg, , Germany
Ulm, , Germany
Reggio Emilia, , Italy
Eindhoven, , Netherlands
Maastricht, , Netherlands
Nieuwegein, , Netherlands
Rotterdam, , Netherlands
Skövde, , Sweden
Zurich, , Switzerland
Liverpool, , United Kingdom
Middlesbrough, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSR-REVERSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.